<div id="readability-page-1"><div><p><span>Lyons Gary A Director of Neurocrine Biosciences Inc [NBIX] filed a Form 4 on December 4, 2025 with the Securities and Exchange Commission disclosing the following changes in ownership:</span></p><div><table><tbody><tr><th><span>Date</span></th><th><span>Transaction</span></th><th><span>Shares</span></th><th><span>Price</span></th><th><span>Value</span></th></tr><tr><td><span>12/3/25</span></td><td><span>Exercise(1)</span></td><td><span>15,000</span></td><td><span>$47.89</span></td><td><span>$718,350</span></td></tr><tr><td><span>12/3/25</span></td><td><span>Planned Sale(2)</span></td><td><span>15,000</span></td><td><span>$152.61</span></td><td><span>$2,289,083</span></td></tr></tbody></table></div><p><span>Ending Holdings: 120,482 (5,983 - Direct, 114,499 - Indirect)</span></p><div><table><tbody><tr><td><span>(1)</span></td><td><span>Exercised 5.5 months before expiration date.</span></td></tr><tr><td><span>(2)</span></td><td><span>Executed pursuant to a prearranged trading plan (10b5-1).</span></td></tr></tbody></table></div><p><span>For a free trial, or to learn more about our insider trading analysis and data services, please visit http://www.washingtonservice.com or contact us at (301) 913-5100 or send an email to info@washingtonservice.com.</span></p><p><span>Founded in 1970, The Washington Service provides securities professionals with financial, economic and public policy research and data.</span></p><span> </span></div></div>

NBIX

<p>Gary A. Lyons, Director of Neurocrine Biosciences Inc, sold 15,000 shares worth $2.3M on December 3, 2025, under a prearranged trading plan. The shares were exercised at $47.89 and sold at $152.61. Lyons' ending holdings are 120,482 shares. The transaction was disclosed in a Form 4 filed with the SEC.</p>

Dir Lyons Sells 15,000 ($2.3M) Of Neurocrine Biosciences Inc [NBIX]